Wilczak W - Search Results

1

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.

Melling N, Rashed M, Schroeder C, Hube-Magg C, Kluth M, Lang D, Simon R, Möller-Koop C, Steurer S, Sauter G, Jacobsen F, Büscheck F, Wittmer C, Clauditz T, Krech T, Tsourlakis MC, Minner S, Huland H, Graefen M, Budäus L, Thederan I, Salomon G, Schlomm T, Wilczak W. Melling N, et al. Among authors: wilczak w. Int J Mol Sci. 2017 Jan 29;18(2):286. doi: 10.3390/ijms18020286. Int J Mol Sci. 2017. PMID: 28146062 Free PMC article.

2

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.

El Gammal AT, Brüchmann M, Zustin J, Isbarn H, Hellwinkel OJ, Köllermann J, Sauter G, Simon R, Wilczak W, Schwarz J, Bokemeyer C, Brümmendorf TH, Izbicki JR, Yekebas E, Fisch M, Huland H, Graefen M, Schlomm T. El Gammal AT, et al. Among authors: wilczak w. Clin Cancer Res. 2010 Jan 1;16(1):56-64. doi: 10.1158/1078-0432.CCR-09-1423. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028754

3

Y chromosome loss is a frequent early event in urothelial bladder cancer.

Minner S, Kilgué A, Stahl P, Weikert S, Rink M, Dahlem R, Fisch M, Höppner W, Wagner W, Bokemeyer C, Terracciano L, Simon R, Sauter G, Wilczak W. Minner S, et al. Among authors: wilczak w. Pathology. 2010 Jun;42(4):356-9. doi: 10.3109/00313021003767298. Pathology. 2010. PMID: 20438408

4

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

Minner S, Wittmer C, Graefen M, Salomon G, Steuber T, Haese A, Huland H, Bokemeyer C, Yekebas E, Dierlamm J, Balabanov S, Kilic E, Wilczak W, Simon R, Sauter G, Schlomm T. Minner S, et al. Among authors: wilczak w. Prostate. 2011 Feb 15;71(3):281-8. doi: 10.1002/pros.21241. Epub 2010 Aug 31. Prostate. 2011. PMID: 20809553

5

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

Clauditz TS, Reiff M, Gravert L, Gnoss A, Tsourlakis MC, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W. Clauditz TS, et al. Among authors: wilczak w. Pathology. 2011 Aug;43(5):459-64. doi: 10.1097/PAT.0b013e3283484a60. Pathology. 2011. PMID: 21670724

6

Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.

Minner S, Kraetzig F, Tachezy M, Kilic E, Graefen M, Wilczak W, Bokemeyer C, Huland H, Sauter G, Schlomm T. Minner S, et al. Among authors: wilczak w. Hum Pathol. 2011 Dec;42(12):1946-52. doi: 10.1016/j.humpath.2011.02.017. Epub 2011 Jun 17. Hum Pathol. 2011. PMID: 21683980

7

Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.

Stahl PR, Kilgué A, Tennstedt P, Minner S, Krohn A, Simon R, Krause GV, Izbicki J, Graefen M, Sauter G, Schlomm T, Wilczak W. Stahl PR, et al. Among authors: wilczak w. Prostate. 2012 Jun 1;72(8):898-903. doi: 10.1002/pros.21492. Epub 2011 Sep 28. Prostate. 2012. PMID: 21956681

8

Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.

Minner S, Rump D, Tennstedt P, Simon R, Burandt E, Terracciano L, Moch H, Wilczak W, Bokemeyer C, Fisch M, Sauter G, Eichelberg C. Minner S, et al. Among authors: wilczak w. Cancer. 2012 Mar 1;118(5):1268-75. doi: 10.1002/cncr.26436. Cancer. 2012. PMID: 22161775 Free article.

9

High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.

Minner S, Luebke AM, Kluth M, Bokemeyer C, Jänicke F, Izbicki J, Schlomm T, Sauter G, Wilczak W. Minner S, et al. Among authors: wilczak w. Histopathology. 2012 Sep;61(3):445-53. doi: 10.1111/j.1365-2559.2012.04240.x. Epub 2012 Mar 28. Histopathology. 2012. PMID: 22463702

10

Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.

Grob TJ, Heilenkötter U, Geist S, Paluchowski P, Wilke C, Jaenicke F, Quaas A, Wilczak W, Choschzick M, Sauter G, Lebeau A. Grob TJ, et al. Among authors: wilczak w. Breast Cancer Res Treat. 2012 Jul;134(2):561-7. doi: 10.1007/s10549-012-2092-7. Epub 2012 May 19. Breast Cancer Res Treat. 2012. PMID: 22610646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters